TY - JOUR
T1 - Home telemonitoring study for Japanese patients with heart failure (HOMES-HF)
T2 - Protocol for a multicentre randomised controlled trial
AU - Kotooka, Norihiko
AU - Asaka, Machiko
AU - Sato, Yasunori
AU - Kinugasa, Yoshiharu
AU - Nochioka, Kotaro
AU - Mizuno, Atsushi
AU - Nagatomo, Daisuke
AU - Mine, Daigo
AU - Yamada, Yoko
AU - Eguchi, Kazuo
AU - Hanaoka, Hideki
AU - Inomata, Takayuki
AU - Fukumoto, Yoshihiro
AU - Yamamoto, Kazuhiro
AU - Tsutsui, Hiroyuki
AU - Masuyama, Tohru
AU - Kitakaze, Masafumi
AU - Inoue, Teruo
AU - Shimokawa, Hiroaki
AU - Momomura, Shin Ichi
AU - Seino, Yoshihiko
AU - Node, Koichi
PY - 2013
Y1 - 2013
N2 - Introduction: Despite the encouraging results from several randomised controlled trials (RCTs) and metaanalyses, the ability of home telemonitoring for heart failure (HF) to improve patient outcomes remains controversial as a consequence of the two recent largescale RCTs. However, it has been suggested that there is a subgroup of patients with HF who may benefit from telemonitoring. The aim of the present study was to investigate whether an HF management programme using telemonitoring could improve outcomes in patients with HF under the Japanese healthcare system. Methods and analysis: The Home Telemonitoring Study for Japanese Patients with Heart Failure (HOMES-HF) study is a prospective, multicentre RCT to investigate the effectiveness of home telemonitoring on the primary composite endpoint of all-cause death and rehospitalisation due to worsening HF in recently admitted HF patients (aged 20 and older, New York Heart Association classes II-III). The telemonitoring system is an automated physiological monitoring system including body weight, blood pressure and pulse rate by full-time nurses 7 days a week. Additionally, the system was designed to make it a high priority to support patient's self-care instead of an early detection of HF decompensation. A total sample size of 420 patients is planned according to the Schoenfeld and Richter method. Eligible patients are randomly assigned via a website to either the telemonitoring group or the usual care group by using a minimisation method with biased-coin assignment balancing on age, left ventricular ejection fraction and a history of ischaemic heart disease. Participants will be enrolled until August 2013 and followed until August 2014. Time to events will be estimated using the Kaplan-Meier method, and HRs and 95% CIs will be calculated using the Cox proportional hazards models with stratification factors. Trial Registration: The study is registered at UMIN Clinical Trials Registry (UMIN000006839).
AB - Introduction: Despite the encouraging results from several randomised controlled trials (RCTs) and metaanalyses, the ability of home telemonitoring for heart failure (HF) to improve patient outcomes remains controversial as a consequence of the two recent largescale RCTs. However, it has been suggested that there is a subgroup of patients with HF who may benefit from telemonitoring. The aim of the present study was to investigate whether an HF management programme using telemonitoring could improve outcomes in patients with HF under the Japanese healthcare system. Methods and analysis: The Home Telemonitoring Study for Japanese Patients with Heart Failure (HOMES-HF) study is a prospective, multicentre RCT to investigate the effectiveness of home telemonitoring on the primary composite endpoint of all-cause death and rehospitalisation due to worsening HF in recently admitted HF patients (aged 20 and older, New York Heart Association classes II-III). The telemonitoring system is an automated physiological monitoring system including body weight, blood pressure and pulse rate by full-time nurses 7 days a week. Additionally, the system was designed to make it a high priority to support patient's self-care instead of an early detection of HF decompensation. A total sample size of 420 patients is planned according to the Schoenfeld and Richter method. Eligible patients are randomly assigned via a website to either the telemonitoring group or the usual care group by using a minimisation method with biased-coin assignment balancing on age, left ventricular ejection fraction and a history of ischaemic heart disease. Participants will be enrolled until August 2013 and followed until August 2014. Time to events will be estimated using the Kaplan-Meier method, and HRs and 95% CIs will be calculated using the Cox proportional hazards models with stratification factors. Trial Registration: The study is registered at UMIN Clinical Trials Registry (UMIN000006839).
UR - http://www.scopus.com/inward/record.url?scp=84878767847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878767847&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2013-002972
DO - 10.1136/bmjopen-2013-002972
M3 - Article
AN - SCOPUS:84878767847
SN - 2044-6055
VL - 3
JO - BMJ Open
JF - BMJ Open
IS - 6
M1 - e002972
ER -